After years of collaborating on diverse research efforts to better understand, diagnose, and treat migraines, the Hartford HealthCare (HHC) Ayer Neuroscience Institute Headache Center and the internationally recognized Migraine Research Foundation (MRF) recently announced an official, ongoing collaboration.
The Migraine Research Foundation closed in late 2021 and directed more than $1.25 million to the Headache Center to be used for headache research and administration of its ongoing grant program. MRF Founder and Executive Director Cathy Glaser has been named Co-Chair of the Headache Center Research Council and will join Co-Chair Dr. Brian Grosberg, the center’s medical director.
“Our work is far from complete, but the next chapter of the Migraine Research Foundation is just beginning,” Glaser said, adding that the decision to partner with Hartford HealthCare was made after an extensive international search. “We find that HHC is fully aligned with MRF’s goals and values. I will work closely with them to expand the reach and scope of their research program and continue our legacy.”
The connection promises mutual benefit. The Headache Center, Glaser said, is an integrated, system-wide, interdisciplinary program perfectly positioned to “perform influential, patient-centric research to benefit patients and advance the field of headache medicine.”
At the same time, Dr. Grosberg sees the power of leveraging the Migraine Research Foundation’s “great body of knowledge and network to expand our capabilities and make us a leader in headache research.”
In the newly structured Headache Center Research Program, Dr. Allison Verhaak as Director of Research and Dr. Dale Bond will serve as Director of Research Integration. The multidisciplinary Headache Research Council will continue to meet monthly and includes specialists in areas such as behavioral health, rehabilitation, women’s health, pain management, integrative medicine, medical weight loss, sleep medicine and diagnostic imaging.
“It was this interdisciplinary collaboration that prompted Cathy to join us,” said Dr. Grosberg. “This is unique in the country, if not in the world. This interdisciplinary infrastructure offers the opportunity to conduct synergistic studies that are truly meaningful in improving patient outcomes and advancing the field of headache medicine.”